T1	Participants 61 66	women
T2	Participants 98 299	333 seronegative African American female drug users (aged 18-59 years) participating in an HIV intervention and with higher levels of emotional distress, specifically symptoms of depression and anxiety
T3	Participants 1611 1673	high-risk women who may be most resistant to behavioral change
